COVID-19 in cancer patients: clinical characteristics and outcome: an analysis of the LEOSS registry

Since the early SARS-CoV-2 pandemic, cancer patients have been assumed to be at higher risk for severe COVID-19. Here, we present an analysis of cancer patients from the LEOSS (Lean European Open Survey on SARS-CoV-2 Infected Patients) registry to determine whether cancer patients are at higher risk...

Full description

Saved in:
Bibliographic Details
Main Authors: Rüthrich, Maria Madeleine (Author) , Giessen-Jung, C. (Author) , Borgmann, S. (Author) , Classen, A. Y. (Author) , Dolff, S. (Author) , Grüner, B. (Author) , Hanses, F. (Author) , Isberner, N. (Author) , Köhler, P. (Author) , Lanznaster, J. (Author) , Merle, Uta (Author) , Nadalin, S. (Author) , Piepel, C. (Author) , Schneider, J. (Author) , Schons, M. (Author) , Strauss, R. (Author) , Tometten, L. (Author) , Vehreschild, J. J. (Author) , Lilienfeld-Toal, M. von (Author) , Beutel, G. (Author) , Wille, K. (Author)
Format: Article (Journal)
Language:English
Published: February 2021
In: Annals of hematology
Year: 2021, Volume: 100, Issue: 2, Pages: 383-393
ISSN:1432-0584
DOI:10.1007/s00277-020-04328-4
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00277-020-04328-4
Get full text
Author Notes:Maria Madeleine Rüthrich, C. Giessen-Jung, S. Borgmann, A.Y. Classen, S. Dolff, B. Grüner, F. Hanses, N. Isberner, P. Köhler, J. Lanznaster, U. Merle, S. Nadalin, C. Piepel, J. Schneider, M. Schons, R. Strauss, L. Tometten, J.J. Vehreschild, M. von Lilienfeld-Toal, G. Beutel, K. Wille, on behalf of the LEOSS Study Group

MARC

LEADER 00000caa a2200000 c 4500
001 1887755055
003 DE-627
005 20240703172944.0
007 cr uuu---uuuuu
008 240503s2021 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00277-020-04328-4  |2 doi 
035 |a (DE-627)1887755055 
035 |a (DE-599)KXP1887755055 
035 |a (OCoLC)1443669967 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rüthrich, Maria Madeleine  |d 1990-  |e VerfasserIn  |0 (DE-588)1203565593  |0 (DE-627)1688544569  |4 aut 
245 1 0 |a COVID-19 in cancer patients: clinical characteristics and outcome  |b an analysis of the LEOSS registry  |c Maria Madeleine Rüthrich, C. Giessen-Jung, S. Borgmann, A.Y. Classen, S. Dolff, B. Grüner, F. Hanses, N. Isberner, P. Köhler, J. Lanznaster, U. Merle, S. Nadalin, C. Piepel, J. Schneider, M. Schons, R. Strauss, L. Tometten, J.J. Vehreschild, M. von Lilienfeld-Toal, G. Beutel, K. Wille, on behalf of the LEOSS Study Group 
264 1 |c February 2021 
300 |b Illustrationen, Diagramme 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 7. November 2020 
500 |a Gesehen am 03.05.2024 
520 |a Since the early SARS-CoV-2 pandemic, cancer patients have been assumed to be at higher risk for severe COVID-19. Here, we present an analysis of cancer patients from the LEOSS (Lean European Open Survey on SARS-CoV-2 Infected Patients) registry to determine whether cancer patients are at higher risk. 
650 4 |a Adjusted analysis 
650 4 |a Cancer patients 
650 4 |a Cohort study 
650 4 |a COVID-19 
650 4 |a LEOSS 
650 4 |a Pandemic 
650 4 |a SARS-CoV-2 
700 1 |a Giessen-Jung, C.  |e VerfasserIn  |4 aut 
700 1 |a Borgmann, S.  |e VerfasserIn  |4 aut 
700 1 |a Classen, A. Y.  |e VerfasserIn  |4 aut 
700 1 |a Dolff, S.  |e VerfasserIn  |4 aut 
700 1 |a Grüner, B.  |e VerfasserIn  |4 aut 
700 1 |a Hanses, F.  |e VerfasserIn  |4 aut 
700 1 |a Isberner, N.  |e VerfasserIn  |4 aut 
700 1 |a Köhler, P.  |e VerfasserIn  |4 aut 
700 1 |a Lanznaster, J.  |e VerfasserIn  |4 aut 
700 1 |a Merle, Uta  |d 1974-  |e VerfasserIn  |0 (DE-588)123211069  |0 (DE-627)706210174  |0 (DE-576)293606854  |4 aut 
700 1 |a Nadalin, S.  |e VerfasserIn  |4 aut 
700 1 |a Piepel, C.  |e VerfasserIn  |4 aut 
700 1 |a Schneider, J.  |e VerfasserIn  |4 aut 
700 1 |a Schons, M.  |e VerfasserIn  |4 aut 
700 1 |a Strauss, R.  |e VerfasserIn  |4 aut 
700 1 |a Tometten, L.  |e VerfasserIn  |4 aut 
700 1 |a Vehreschild, J. J.  |e VerfasserIn  |4 aut 
700 1 |a Lilienfeld-Toal, M. von  |e VerfasserIn  |4 aut 
700 1 |a Beutel, G.  |e VerfasserIn  |4 aut 
700 1 |a Wille, K.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Annals of hematology  |d Berlin : Springer, 1991  |g 100(2021), 2 vom: Feb., Seite 383-393  |h Online-Ressource  |w (DE-627)253389852  |w (DE-600)1458429-3  |w (DE-576)072283157  |x 1432-0584  |7 nnas  |a COVID-19 in cancer patients: clinical characteristics and outcome an analysis of the LEOSS registry 
773 1 8 |g volume:100  |g year:2021  |g number:2  |g month:02  |g pages:383-393  |g extent:11  |a COVID-19 in cancer patients: clinical characteristics and outcome an analysis of the LEOSS registry 
856 4 0 |u https://doi.org/10.1007/s00277-020-04328-4  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240503 
993 |a Article 
994 |a 2021 
998 |g 123211069  |a Merle, Uta  |m 123211069:Merle, Uta  |d 910000  |d 910100  |d 50000  |e 910000PM123211069  |e 910100PM123211069  |e 50000PM123211069  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 11 
999 |a KXP-PPN1887755055  |e 4520283760 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Maria Madeleine Rüthrich, C. Giessen-Jung, S. Borgmann, A.Y. Classen, S. Dolff, B. Grüner, F. Hanses, N. Isberner, P. Köhler, J. Lanznaster, U. Merle, S. Nadalin, C. Piepel, J. Schneider, M. Schons, R. Strauss, L. Tometten, J.J. Vehreschild, M. von Lilienfeld-Toal, G. Beutel, K. Wille, on behalf of the LEOSS Study Group"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"February 2021"}],"recId":"1887755055","language":["eng"],"note":["Online veröffentlicht: 7. November 2020","Gesehen am 03.05.2024"],"person":[{"display":"Rüthrich, Maria Madeleine","family":"Rüthrich","given":"Maria Madeleine","role":"aut"},{"given":"C.","role":"aut","display":"Giessen-Jung, C.","family":"Giessen-Jung"},{"given":"S.","role":"aut","display":"Borgmann, S.","family":"Borgmann"},{"display":"Classen, A. Y.","family":"Classen","given":"A. Y.","role":"aut"},{"family":"Dolff","display":"Dolff, S.","role":"aut","given":"S."},{"display":"Grüner, B.","family":"Grüner","given":"B.","role":"aut"},{"role":"aut","given":"F.","family":"Hanses","display":"Hanses, F."},{"given":"N.","role":"aut","display":"Isberner, N.","family":"Isberner"},{"given":"P.","role":"aut","display":"Köhler, P.","family":"Köhler"},{"given":"J.","role":"aut","display":"Lanznaster, J.","family":"Lanznaster"},{"display":"Merle, Uta","family":"Merle","given":"Uta","role":"aut"},{"role":"aut","given":"S.","family":"Nadalin","display":"Nadalin, S."},{"given":"C.","role":"aut","display":"Piepel, C.","family":"Piepel"},{"role":"aut","given":"J.","family":"Schneider","display":"Schneider, J."},{"display":"Schons, M.","family":"Schons","given":"M.","role":"aut"},{"display":"Strauss, R.","family":"Strauss","given":"R.","role":"aut"},{"given":"L.","role":"aut","display":"Tometten, L.","family":"Tometten"},{"given":"J. J.","role":"aut","display":"Vehreschild, J. J.","family":"Vehreschild"},{"role":"aut","given":"M. von","family":"Lilienfeld-Toal","display":"Lilienfeld-Toal, M. von"},{"role":"aut","given":"G.","family":"Beutel","display":"Beutel, G."},{"family":"Wille","display":"Wille, K.","role":"aut","given":"K."}],"relHost":[{"recId":"253389852","language":["eng"],"note":["Gesehen am 24.04.2025","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 80.2001: Supplement"],"origin":[{"dateIssuedKey":"1991","publisher":"Springer","dateIssuedDisp":"1991-","publisherPlace":"Berlin ; Heidelberg ; New York"}],"pubHistory":["62, 1 (Februrary 1991)-"],"titleAlt":[{"title":"Hematology"}],"disp":"COVID-19 in cancer patients: clinical characteristics and outcome an analysis of the LEOSS registryAnnals of hematology","part":{"year":"2021","text":"100(2021), 2 vom: Feb., Seite 383-393","volume":"100","extent":"11","issue":"2","pages":"383-393"},"id":{"issn":["1432-0584"],"eki":["253389852"],"zdb":["1458429-3"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"organ of: Gesellschaft für Thrombose- und Hämostaseforschung, DGHO, Deutsche Gesellschaft für Hämatologie und Onkologie e.V., ÖGHO, Österreichische Gesellschaft für Hämatologie und Onkologie","title":"Annals of hematology","title_sort":"Annals of hematology"}]}],"physDesc":[{"extent":"11 S.","noteIll":"Illustrationen, Diagramme"}],"title":[{"subtitle":"an analysis of the LEOSS registry","title_sort":"COVID-19 in cancer patients: clinical characteristics and outcome","title":"COVID-19 in cancer patients: clinical characteristics and outcome"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1007/s00277-020-04328-4"],"eki":["1887755055"]}} 
SRT |a RUETHRICHMCOVID19INC2021